An Italian Cost-effectiveness Analysis of Paclitaxel Albumin (nab Paclitaxel) Vs Solvent-based Paclitaxel for Metastatic Breast Cancer Patients - the CONSTANZA Study

被引：0
|
作者：
Lazzaro, C. [1 ]
Bordonaro, R. [2 ]
Cognetti, F. [3 ]
Fabi, A. [3 ]
De Placido, S. [4 ]
Arpino, G. [4 ]
Marchetti, P. [5 ]
Botticelli, A. [5 ]
Pronzato, P. [6 ]
Martelli, E. [7 ]
机构：
[1] Hlth Econ Res & Consulting, Studio Econ Sanit, Milan, Italy
[2] Publ Hosp Trust Garibaldi, Dept Med Oncol, Catania, Italy
[3] Regina Elena Inst Canc Res, Dept Med Oncol A, Rome, Italy
[4] Federico II Univ Hosp, Sch Med, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
[5] Publ Hosp Trust StAndrea, Dept Med Oncol, Rome, Italy
[6] Natl Canc Res Inst, Dept Med Oncol A, Genoa, Italy
[7] Celgene Srl, Hlth Econ, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [11] Randomized controlled comparative clinical pharmacokinetic study of nab-paclitaxel and solvent-based paclitaxel in Chinese patients (pts) with metastatic breast cancer (MBC)
    Li, S.
    Guan, Z.
    Yao, Z.
    Teng, X.
    Liao, H.
    Deng, L.
    Pan, Y.
    Yao, X.
    Hawkins, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [12] NAB-PACLITAXEL OR DOCETAXEL AS ALTERNATIVES TO SOLVENT-BASED PACLITAXEL IN METASTATIC BREAST CANCER (MBC): A COST UTILITY ANALYSIS FROM A CHINESE HEALTH CARE PERSPECTIVE
    Dranitsaris, G.
    Yu, B.
    Qing, Z.
    King, J.
    Zhang, A.
    Kaura, S.
    VALUE IN HEALTH, 2014, 17 (07) : A642 - A642
  • [13] ADVERSE EVENTS AND HOSPITALIZATIONS AMONG METASTATIC BREAST CANCER PATIENTS INITIATING SOLVENT BASED (SB)-PACLITAXEL OR ALBUMIN BOUND (NAB)-PACLITAXEL
    Bonafede, M. M.
    Cai, Q.
    Princic, N.
    Tran, O., V
    Parisi, M.
    VALUE IN HEALTH, 2016, 19 (03) : A133 - A134
  • [14] INDIRECT COMPARISON AND UK COST-EFFECTIVENESS ANALYSIS OF PACLITAXEL ALBUMIN VS DOCETAXEL FOR PRETREATED METASTATIC BREAST CANCER
    Prunieras, F.
    McLeod, E.
    Lloyd, A.
    Canney, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 107 - 108
  • [15] A cost utility analysis from a Chinese health care perspective of Nab-paclitaxel or docetaxel, both as alternatives to solvent-based paclitaxel in metastatic breast cancer (MBC)
    Dranitsaris, George
    Yu, Bo
    King, Jennifer
    Zhang, Adams
    Kaura, Satyn
    Qing, Zhai
    CANCER RESEARCH, 2015, 75
  • [16] Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer
    Guan, Zhong-Zhen
    Li, Qing Li
    Feng, Fengyi
    Jiang, Zefei
    Shen, Zhenzhou
    Yu, Shiying
    Fen, Jifeng
    Huang, Jianjin
    Yao, Zhiwen
    Bhar, Paul
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (03) : 165 - 174
  • [17] Overall survival analysis of a randomized phase III trial comparing nab-paclitaxel with solvent-based paclitaxel in patients with metastatic breast cancer previously treated with anthracycline
    Davidson, N.
    Tjulandin, S.
    O'Shaughnessy, J.
    Bhar, P.
    Gradishar, W.
    EJC SUPPLEMENTS, 2008, 6 (07): : 218 - 218
  • [18] Randomized study comparing nab-paclitaxel with solvent- based paclitaxel in Chinese patients (pts) with metastatic breast cancer (MBC)
    Guan, Z.
    Feng, F.
    Li, Q. L.
    Jiang, Z.
    Shen, Z.
    Yu, S.
    Feng, J.
    Huang, J.
    Yao, Z.
    Hawkins, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [19] Cost-effectiveness analysis of atezolizumab plus nab-paclitaxel for untreated metastatic triple-negative breast cancer
    Li, Jiahao
    Zhang, Tiantian
    Lu, Peiyao
    Zhao, Jianfu
    Chen, Lin
    Jiang, Jie
    IMMUNOTHERAPY, 2020, 12 (10) : 705 - 713
  • [20] Randomized phase 3 clinical trial comparing 130-nanometer albumin bound paclitaxel with solvent-based paclitaxel in Chinese patients with metastatic breast cancer
    Guan, Z.
    Feng, F. Y.
    Li, L. Q.
    Zefei, J. J.
    Shen, Z. Z.
    Yu, S.
    Feng, J.
    Huang, J.
    Yao, Z.
    Hawkins, M. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 218 - 218
12345